ResearcherBursa Uludağ Üni̇versi̇tesi̇Active in the last 2 years
Didem Karakaş
Matched on ORCID iD 0000-0002-3781-6834; OpenAlex author ID A5033075221. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 40
2023: 1 paper · 2024: none · 2025: 5 papers · 2026: 1 paper
Papers 7
- Pancreatic ductal adenocarcinoma: The Vision of Heracles. Co-author DOI 10.1016/j.ccell.2026.07.014↗
- Fibrotic Fortresses and Therapeutic Frontiers: Pancreatic Stellate Cells and the Extracellular Matrix in Pancreatic Cancer. First author DOI 10.1002/cam4.70788↗
- Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses. Co-author DOI 10.1016/j.ccell.2025.09.003↗
- Organoids, tissue slices and organotypic cultures: Advancing our understanding of pancreatic ductal adenocarcinoma through in vitro and ex vivo models. Co-author DOI 10.1016/j.semcancer.2024.12.003↗
- eEF2K is a poor prognostic factor and novel molecular target in pancreatic cancer: regulating tumor growth and progression via the tumor microenvironment. Co-author DOI 10.1038/s41419-025-07803-w↗
- Impact of different 3D culture environments on spheroid morphology, drug response, and invasion in pancreatic cancer cells. Co-author DOI 10.1186/s13104-025-07524-5↗
- Targeting Periostin Expression Makes Pancreatic Cancer Spheroids More Vulnerable to Natural Killer Cells. Co-author DOI 10.3390/biomedicines11020270↗
Closest collaborators
The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sıla Sığırlı · 3 shared papers, 2025 · strength 1.36
- Paper Fibrotic Fortresses and Therapeutic Frontiers: Pancreatic Stellate Cells and the Extracellular Matrix in Pancreatic Can… DOI 10.1002/cam4.70788↗
- Paper Impact of different 3D culture environments on spheroid morphology, drug response, and invasion in pancreatic cancer ce… DOI 10.1186/s13104-025-07524-5↗
- Paper Organoids, tissue slices and organotypic cultures: Advancing our understanding of pancreatic ductal adenocarcinoma thro… DOI 10.1016/j.semcancer.2024.12.003↗
- Engı̇n Ulukaya · 2 shared papers, 2023–2025 · strength 0.46
- Paper eEF2K is a poor prognostic factor and novel molecular target in pancreatic cancer: regulating tumor growth and progress… DOI 10.1038/s41419-025-07803-w↗
- Paper Targeting Periostin Expression Makes Pancreatic Cancer Spheroids More Vulnerable to Natural Killer Cells. DOI 10.3390/biomedicines11020270↗
- Kıvanç Görgülü · 2 shared papers, 2025–2026 · strength 0.35
- Carmen Mota Reyes · 2 shared papers, 2025–2026 · strength 0.35
- Roland Rad · 2 shared papers, 2025–2026 · strength 0.35
- İhsan Ekin Demir · 2 shared papers, 2025–2026 · strength 0.35
- Hana Algül · 2 shared papers, 2025–2026 · strength 0.35
- Guralp Onur Ceyhan · 2 shared papers, 2025–2026 · strength 0.35
- Dieter Saur · 2 shared papers, 2025–2026 · strength 0.35
- Seçil Ak Aksoy · 1 shared paper, 2025 · strength 0.28
- Jelena Grahovac · 1 shared paper, 2025 · strength 0.28
- Giulia Lencioni · 1 shared paper, 2025 · strength 0.28
- Maarten F. Bijlsma · 1 shared paper, 2025 · strength 0.28
- Julie Earl · 1 shared paper, 2025 · strength 0.28
- Ahmed Amine Ashour · 1 shared paper, 2025 · strength 0.24
- Bülent Özpolat · 1 shared paper, 2025 · strength 0.24
- Pilhan Kim · 1 shared paper, 2026 · strength 0.19
- Marina Lesina · 1 shared paper, 2026 · strength 0.19
- Chiara Falcomatà · 1 shared paper, 2026 · strength 0.19
- Marie C. Hasselluhn · 1 shared paper, 2026 · strength 0.19
- Yetiş Gültekin · 1 shared paper, 2026 · strength 0.19
- Matthias M. Gaida · 1 shared paper, 2026 · strength 0.19
- Marina Pasca di Magliano · 1 shared paper, 2026 · strength 0.19
- Laura DeLong Wood · 1 shared paper, 2026 · strength 0.19
- Raghu Kalluri · 1 shared paper, 2026 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.